NCT05381688

Brief Summary

Research from our group has demonstrated modulation of PEFR in patients with STN and PAG stimulation. However, the effect of VIM (motor thalamus) stimulation remains to be investigated. Our group has also been involved in research that indicates that VIM stimulation may reduce perception of breathlessness. However, methodological factors limit the conclusions that can be drawn from this prior work. N-of-1 trials, organised as a randomised multiphase crossover design, are uniquely well suited for DBS research where stimulation can be switched ON and OFF, and with simple tests that can be done quickly, multiple times. PEFR and breath-holding are simple tests that we will test in this way. Other respiratory tests will be carried out along side, as optional, in a single phase design. We aim to offer this study to a continuous cohort of patients scheduled to undergo VIM (ET/DT) DBS at our institution. We will establish a pre-operative baseline of respiratory function, and then perform the n-of-1 trial post-operatively, soon after the patient returns to hospital to receive their DBS programming.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

September 9, 2021

Completed
8 months until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

November 17, 2025

Status Verified

May 1, 2022

Enrollment Period

11 months

First QC Date

April 27, 2021

Last Update Submit

November 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Breath-hold (urge to breath)

    Time from start of breath-hold to urge to breathe

    3 months post-operative, ON and OFF: randomised, cross over, 5-phase design

Secondary Outcomes (5)

  • Breath-hold (break point)

    3 months post-operative, ON and OFF: randomised, cross over, 5-phase design

  • Peak Expiratory Flow Rate

    3 months post-operative, ON and OFF: randomised, cross over, 5-phase design

  • Dyspnoea-12 Questionnaire

    Baseline and 3 months post-operative

  • Oscillometry

    Baseline and 3 months post-operative ON and OFF

  • Maximum inspiratory pressure

    Baseline and 3 months post-operative ON and OFF

Study Arms (2)

ET VIM DBS patients

Essential tremor patients scheduled for VIM DBS

Procedure: VIM DBS

DT VIM DBS patients

Dystonic tremor patients scheduled for VIM DBS

Procedure: VIM DBS

Interventions

VIM DBSPROCEDURE

Stereotactic deep brain stimulation of ventral intermediate nucleus of thalamus

DT VIM DBS patientsET VIM DBS patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Sequential cohort of patients with movement disorders (ET and DT) who are scheduled for VIM DBS at John Radcliffe Hospital. All will be contacted by a member of clinical care team for the study to be offered.

You may qualify if:

  • Scheduled for VIM DBS
  • Diagnosis of ET or DT

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Essential Tremor

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Alex L Green, FRCS

    University of Oxford

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2021

First Posted

May 19, 2022

Study Start

September 9, 2021

Primary Completion

July 31, 2022

Study Completion

July 31, 2022

Last Updated

November 17, 2025

Record last verified: 2022-05